Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · IEX Real-Time Price · USD
1.650
-0.030 (-1.79%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Regulus Therapeutics Market Cap
Regulus Therapeutics has a market cap or net worth of $108.02 million as of July 22, 2024. Its market cap has increased by 277.69% in one year.
Market Cap
108.02M
Enterprise Value
11.81M
1-Year Change
277.69%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since December 31, 2012, Regulus Therapeutics's market cap has decreased from $225.70M to $108.02M, a decrease of -52.14%. That is a compound annual growth rate of -6.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 108.00M | 316.99% |
Dec 29, 2023 | 25.90M | 12.12% |
Dec 30, 2022 | 23.10M | -15.69% |
Dec 31, 2021 | 27.40M | -48.20% |
Dec 31, 2020 | 52.90M | 184.41% |
Dec 31, 2019 | 18.60M | 129.63% |
Dec 31, 2018 | 8.10M | -92.51% |
Dec 29, 2017 | 108.10M | -9.24% |
Dec 30, 2016 | 119.10M | -73.90% |
Dec 31, 2015 | 456.40M | -41.46% |
Dec 31, 2014 | 779.60M | 152.54% |
Dec 31, 2013 | 308.70M | 36.77% |
Dec 31, 2012 | 225.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
aTyr Pharma | 114.55M |
Adagene | 113.38M |
TELA Bio | 112.18M |
FONAR | 112.11M |
Augmedix | 111.16M |
Karyopharm Therapeutics | 110.91M |
Journey Medical | 110.27M |
BrainsWay | 110.01M |